Skip to main content

Advertisement

SpringerLink
Log in

The history of cytomegalovirus and its diseases

  • Review
  • Published:
Medical Microbiology and Immunology Aims and scope Submit manuscript

Abstract

Intranuclear inclusions typical of cytomegalovirus infections were first noticed in 1881 by German scientists who thought they represented protozoa. After viruses were grown in cell cultures, Weller, Smith and Rowe independently isolated and grew CMV from man and mice in 1956–1957. Antibodies in 30–100% of normal adults indicate not only a past infection, but the presence of a present latent infection. The presence of CMV DNA in tissues and most organs surveyed indicates the ubiquity of latent infection. CMV disease requires the virus and some deficiency of immunity such as occurs in the immature fetus, in AIDS, and in transplant patients on immunosuppressive drugs. Antiviral agents can inhibit CMV replication but they cannot prevent or cure latent infections. A pharmacological approach using the many leads in understanding latency is needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ribbert H (1904) Ueber protozoenartige Zellen in der Niere eines syphilitischen Neugeborenen und in der Parotis von Kindern. Zbl All Pathol 15:945–948

    Google Scholar 

  2. Jesionek A, Kiolemenoglou B (1904) Ueber einen Befund von protozoenartigen Gebilden in den Organen eines hereditar-luetischen Foetus. Muenchner Med Wochenschr 51:1905–1907

    Google Scholar 

  3. Lòwenstein C (1907) Ueber protozoenartige Gebilde in den Organen von Kindern. Zbl Allg Pathol 18:513–718

    Google Scholar 

  4. Von Glahn WC, Pappenheimer AM (1925) Intranuclear inclusions in visceral disease. Am J Pathol 1:445–465

    Google Scholar 

  5. Lipschuetz B (1921) Untersuchungen ueber die Aetiologie der Krankheiten der Herpes genitalis. Arch Dermatol Syph 136:428–482

    Article  Google Scholar 

  6. Farber S, Wolbach S (1932) Intranuclear and cytoplasmic inclusions (protozoan-like bodies) in the salivary glands and other organs of children. Am J Pathol 8:123–135

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Wyatt JP, Saxton J, Lee RS, Pinkerton H (1950) Generalized cytomegalic inclusion disease. J Pediatr 36:271–294

    Article  CAS  PubMed  Google Scholar 

  8. Fetterman GH (1952) A new laboratory aid in the diagnosis of inclusion disease of infancy. Clin Pathol 22:424–425

    CAS  Google Scholar 

  9. Minder WH (1953) Die Aetiologie der Cytomegalia infantum. Schweiz Med Wochenschr 83:1180–1182

    CAS  PubMed  Google Scholar 

  10. Enders JF, Weller TH, Robbins FC (1949) Cultivation of the lansing strain of poliomyelitis virus in cultures of various human embryonic tissues. Science 109:85–87

    Article  CAS  PubMed  Google Scholar 

  11. Weller TH, Macauley JC, Craig JM, Wirth P (1957) Isolation of intranuclear inclusion producing agents from infants with illnesses resembling cytomegalic inclusion disease. Proc Soc Exp Biol Med 94:4–12

    Article  PubMed  Google Scholar 

  12. Smith MG (1956) Propagation in tissue cultures of a cytopathogenic virus from human salivary gland virus (SVG) disease. Proc Soc Exp Biol Med 92:424–430

    Article  CAS  PubMed  Google Scholar 

  13. Rowe WP, Hartley JW, Waterman S et al (1956) Cytopathogenic agent resembling human salivary gland virus recovered from tissue cultures of human adenoids. Pro Soc Exp Biol Med 92:418–424

    Article  CAS  Google Scholar 

  14. Weller TH (1953) Serial propagation in vitro of agents producing inclusion bodies derived from varicella and herpes zoster. Proc Soc Exp Biol Med 83:340–346

    Article  CAS  PubMed  Google Scholar 

  15. Weller TH (1970) Cytomegalovirus: the difficult years. J Infect Dis 122:532–539

    Article  CAS  PubMed  Google Scholar 

  16. Weller TH, Hanshaw JB, Scott DE (1960) Serologic differentiation of viruses responsible for cytomegalic inclusion disease. Virology 108:843–868

    Google Scholar 

  17. Boppana SB, Rivera LB, Fowler KB et al (2001) Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 344:1366–1371

    Article  CAS  PubMed  Google Scholar 

  18. Arvin AM, Fast P, Myers M, Plotkin S, Rabinovich R (2004) Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee. Clin Infect Dis 39:233–239

    Article  PubMed  Google Scholar 

  19. Cha TA, Tom E, Kemble GW et al (1996) Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol 70:78–83

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Krech U, Jung M, Jung F (1971) CMV infections in man. S. Karger, Basel, 124 pp

  21. Reynolds DW, Stagno S, Hosty TS et al (1973) Maternal cytomegalovirus excretion and perinatal infection. N Engl J Med 289:1–5

    Article  CAS  PubMed  Google Scholar 

  22. Stagno S, Reynolds DW, Pass RF, Alford CA Jr (1980) Breast milk and the risk of cytomegalovirus infection. N Engl J Med 302:1073–1074

    Article  CAS  PubMed  Google Scholar 

  23. Numazaki Y, Yano N, Morizuka T et al (1970) Primary infection with human cytomegalovirus: virus isolation from healthy infants and pregnant women. Am J Epidemiol 91:410–417

    Article  CAS  PubMed  Google Scholar 

  24. Lamb SB, Stern H (1966) Cytomegalovirus mononucleosis with jaundice as presenting sign. Lancet 2:1003–1007

    Article  CAS  PubMed  Google Scholar 

  25. Chretien JH, McGinnis CG, Muller A (1977) Venereal causes of cytomegalovirus mononucleosis. JAMA 238:1644–1645

    Article  CAS  PubMed  Google Scholar 

  26. Handsfield HH, Chandler SH, Caine VA et al (1985) Cytomegalovirus infection in sex partners: evidence of transmission. J Infect Dis 151:344–348

    Article  CAS  PubMed  Google Scholar 

  27. Drew WL, Sweet ES, Miner RC et al (1984) Multiple infections by cytomegalovirus in patients with acquired immune deficiency syndrome: documentation by southern blot hybridization. J infect Dis 155:891–896

    Google Scholar 

  28. Coutinho RA, Van Dillen PW, Van Lent PA et al (1984) Infection with cytomegalovirus in homosexual men. Br J Vener Dis 60:249–252

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Collier AC, Meyers JD, Corey L et al (1987) Cytomegalovirus infection in homosexual men. Am J Med 82:593–600

    Article  CAS  PubMed  Google Scholar 

  30. Mintz L, Drew WL, Miner RC, Braff EH et al (1983) Cytomegalovirus infections in homosexual men. Ann Intern Med 99:326–329

    Article  CAS  PubMed  Google Scholar 

  31. Reddehase MJ (2006) Cytomegaloviruses: molecular biology and immunology, Caister Academic Press, Norfolk, 619 pp

  32. Ho M, Suwansirikul S, Dowling JN et al (1975) The transplanted kidney as a source of cytomegalovirus infection. New Engl J Med 293:1109–1112

    Article  CAS  PubMed  Google Scholar 

  33. Ho M (1991) Cytomegalovirus: biology and infection, 2nd edn, Chap 13. Plenum, New York, pp 249–300

  34. Hendrix RM, Wagenaar M, Slobbe RL, Bruggeman CA (1997) Widespread presence of cytomegalovirus DNA in tissues of healthy trauma victims. J Clin Pathol 50:59–63

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Sinclair J, Sissons P (1996) Latent and persistent infections of monocytes and macrophages. Intervirology 39:293–301

    Article  CAS  PubMed  Google Scholar 

  36. Pereira L, Maidji E, McDonagh S, Tabata T (2006) Routes of human CMV transmission and infection at the uterine-placental interface. In: Reddehase MJ (ed) Cytomegaloviruses: molecular biology and immunology, Chap 3. Caister Academic Press, Norfolk, pp 29–48

  37. Klemola E, Kaariainen L (1965) Cytomegalovirus as a possible cause of a disease resembling infectious mononucleosis. Br Med J 2:1099–1102

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Rinaldo CR, Levin MJ, Carney WP et al (1979) Interaction of lymphocytes with cytomegalovirus. In: Proffit MR (ed) Virus-lymphocyte interactions: implications for disease. Elsevier-North Holland, Amsterdam, pp 267–282

    Google Scholar 

  39. Saltzman RL, Quirk MR, Jordan MC (1988) Disseminated cytomegalovirus infecton. Molecular ananlysis of virus and leukocyte interactions in viremia. J Clin Invest 81:75–81

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Diosi P, Moldovan E, Tomescu N (1969) Latent cytomegalovirus infection in blood donors. Br Med J 4:660–662

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Armstrong JA, Tarr GC, Ho M et al (1976) Cytomegalovirus infection with in children undergoing open-heart surgery. Yale J Biol Med 49:83–91

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Ho M (1991) Cytomegalovirus: biology and infection, 2nd edn. Plenum, New York, p 177, 440 pp

  43. Yeager AS, Grumet FC, Hafleigh EB et al (1981) Prevention of transfusion-acquired cytomegalovirus infections in newborn infants. J Pediatr 98:281–287

    Article  CAS  PubMed  Google Scholar 

  44. Bowden RA, Sayers M, Flournoy N et al (1986) Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med 314:1006–1010

    Article  CAS  PubMed  Google Scholar 

  45. Demmler GJ (1991) Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis 13:315–329

    Article  CAS  PubMed  Google Scholar 

  46. Gallant JE, Moore RD, Richman DD et al (1992) Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J Infect Dis 166:1223–1227

    Article  CAS  PubMed  Google Scholar 

  47. Verbraak FD, Boom R, Wertheim-van Dillen PM et al (1999) Influence of highly active antiretroviral therapy (HAART) on the development of CMV disease in HIV positive patients at high risk for CMV disease. Br J Ophthalmol 83:1186–1189

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Cohen BA, McArthur JC, Grohman S et al (1993) Neurologic prognosis of cytomegalovirus polyradiculomyelopathy in AIDS. Neurology 43:493–499

    Article  CAS  PubMed  Google Scholar 

  49. Holland NR, Power C, Mathews VP et al (1994) Cytomegalovirus encephalitis in acquired immunodeficiency syndrome (AIDS). Neurology 44:507–514

    Article  CAS  PubMed  Google Scholar 

  50. Haymaker W, Girdany BR, Stephens J et al (1954) Cerebral involvement with advanced periventricular calcification in generalized cytomegalic inclusion disease in the newborn. J Neuropathol Exp Neurol 13:562–586

    Article  CAS  PubMed  Google Scholar 

  51. Price TA, Digioia RA, Simon GL (1992) Ganciclovir treatment of cytomegalovirus ventriculitis in a patient infected with human immunodeficiency virus. Clin Infect Dis 15:606–608

    Article  CAS  PubMed  Google Scholar 

  52. Bartlett JG, Laughon B, Quinn TC (1988) Gastrointestinal complications of AIDS. In: DeVita VT, Hellman S, Rosenberg SA (eds) AIDS, etiology, diagnosis, treatment and prevention, 2nd edn. Lippincott, Philadelphia, pp 227–244

    Google Scholar 

  53. Pereyra F, Rubin RH (2004) Prevention and treatment of cytomegalovirus infection in solid organ transplant recipients. Curr Opin Infect Dis 17:357–361

    Article  CAS  PubMed  Google Scholar 

  54. Ho M (1991) Cytomegalovirus: biology and infection, 2nd edn. Plenum, New York, p 250, 440 pp

  55. Ho M (1991) Cytomegalovirus: biology and infection, 2nd edn. Plenum, New York, p 251, 440 pp

  56. Ho M (1991) Cytomegalovirus: biology and infection, 2nd edn. Plenum, New York, p 257, 440 pp

  57. Meyers JD, Flournoy N, Thomas ED (1986) Risk factors for cytomegalovirus infection after human marrow transplant. J Infect Dis 153:478–488

    Article  CAS  PubMed  Google Scholar 

  58. Peterson PK, Balfour HH, Marker SC et al (1980) Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine 59:283–300

    Article  CAS  PubMed  Google Scholar 

  59. Ho M (1987) Infection and organ transplantation. In: Gelman S (ed) Anesthesia and organ transplantation. WB Saunders, Philadelphia, pp 49–60

    Google Scholar 

  60. Dummer JS, Montero CG, Griffith BP et al (1986) Infection in heart-lung transplant recipients. Transplantation 41:725–729

    Article  CAS  PubMed  Google Scholar 

  61. Rubin RH, Tolkoff-Rubin NE, Oliver D et al (1985) Multicenter seroepidemiologic study of the impact of cytomegalovirus infection on renal transplantation. Transplantation 40:243–249

    Article  CAS  PubMed  Google Scholar 

  62. Chou S, Norman DJ (1985) Effect of OKT3 antibody therapy on cytomegalovirus reactivation in renal transplant recipients. Transplantation Proc 17:2755–2756

    Google Scholar 

  63. Starzl TE, Fung J, Venkataramman R et al (1989) FK 506 for liver, kidney, and pancreas transplantation. Lancet 2:1000–1004

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Thomason AW (1990) FK-506-how much potential? Immunol Today 11:6–9

    Google Scholar 

  65. Spector SA, Davis JL, Singh N (2006) Cytomegalovirus. http://www.antimicrobe.org/12rev.asp

  66. Cheng YC, Huang ES, Lin JC et al (1983) Unique spectrum of activity of 9-[(1,3-dihydro-2-propoxy)methyl]guanine against herpes simplex type 1. Proc Natl Acad USA 80:2767–2770

    Article  CAS  Google Scholar 

  67. Felsenstein D, D’Amico DJ, Hirsch MS et al (1985) Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine. Ann Intern Med 103:377–380

    Article  CAS  PubMed  Google Scholar 

  68. Felsenstein D, D’Amico DJ, Hirsch MS et al (1985) Treastment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine and high-dose corticosteroids. Ann Intern Med 105:214–215

    Google Scholar 

  69. Bach MC, Bagwell SP, Knapp NP et al (1985) 9-(1,3dihydroxy-2-propoxymethyl)guanine for cytomegalovirus infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med 103:381–384

    Article  CAS  PubMed  Google Scholar 

  70. Reed EC, Bowden RA, Dandliker PS et al (1988) Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Ann Intern Med 109:783–78

    Article  CAS  PubMed  Google Scholar 

  71. Lazzarotto T, Dal Monte P, Landini MP (1996) Recent advances in the diagnosis of cytomegalovirus infection. Ann Biol Clin 54:259–265

    CAS  Google Scholar 

  72. Spector SA, Merrill R, Wolf D et al (1992) Detection of human cytomegalovirus in plasma of AIDS patients during acute visceral disease by DNA amplification. J Clin Microbiol 30:2359–2365

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Paya CV (2001) Prevention of cytomegalovirus disease in recipients of solid organ transplants. Clin Infect Dis 32:596–603

    Article  CAS  PubMed  Google Scholar 

  74. Singh N (2005) Late-onset cytomegalovirus disease as a significant complication in organ transplant recipients receiving antiviral prophylaxis: a call to heed mounting evidence. Clin Infect Dis 40:704–708

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 618 Friendship Circle, Pittsburgh, PA, 15241-3998, USA

    Monto Ho

Authors
  1. Monto Ho
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Monto Ho.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ho, M. The history of cytomegalovirus and its diseases. Med Microbiol Immunol 197, 65–73 (2008). https://doi.org/10.1007/s00430-007-0066-x

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00430-007-0066-x

Keywords

Search

Navigation